The Cambridge spinout says the hard part of RNA interference was never silencing - it was getting the molecule to…
South Korea released a care roadmap that pairs AI with smart diapers…
Aiforia's CE-IVD marked pathology models will be sold through PathAI's AISight Marketplace,…
Throne Science presented the first clinical validation of its AI stool classification,…
Fujifilm's Synapse Pathology v3.0 adds more than 50 features and bundles a…
Cancer pathology software from Lunit, a Korean medical AI company, is headed…
The NYSE-listed BDC devotes about 6.7% of assets to early-stage healthcare AI, from cancer screening to clinic operations.
A virtual-cell model trained on 38 million protein measurements matched real treatment…
A pathology AI trained only on frozen sections matched real surgical decisions…
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
Massive Bio has appointed a Seoul-based partner to grow its AI clinical trial matching business…
KAIST's homegrown K-Fold model predicts protein-drug binding structures up to 25 times faster than existing…
Cureety acquires Reimagine Care, pairing AI-driven triage with oncology clinical teams across 250 centers.
The first neuroscience target found through Recursion's $12B AI pact with Roche and Genentech is…
Medicare proposes a standardized payment structure for AI clinical tools based on patient outcomes.
The Czech imaging startup raised 1.5 million euros to deepen its bet on AI-read X-rays…
The $7B AI health company cut payments to customers who referred new business days after…
The startup behind AI molecule models used by Lilly, Novartis and Pfizer hits a $3.8…